2-120346381-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002193.4(INHBB):āc.193G>Cā(p.Glu65Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,519,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002193.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
INHBB | NM_002193.4 | c.193G>C | p.Glu65Gln | missense_variant | 1/2 | ENST00000295228.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
INHBB | ENST00000295228.4 | c.193G>C | p.Glu65Gln | missense_variant | 1/2 | 1 | NM_002193.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151920Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000117 AC: 14AN: 119760Hom.: 1 AF XY: 0.000119 AC XY: 8AN XY: 67156
GnomAD4 exome AF: 0.000118 AC: 162AN: 1367686Hom.: 0 Cov.: 33 AF XY: 0.000110 AC XY: 74AN XY: 675012
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151920Hom.: 0 Cov.: 33 AF XY: 0.0000674 AC XY: 5AN XY: 74204
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | The c.193G>C (p.E65Q) alteration is located in exon 1 (coding exon 1) of the INHBB gene. This alteration results from a G to C substitution at nucleotide position 193, causing the glutamic acid (E) at amino acid position 65 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at